title: Use of PEG-interferon alfa-2a plus ribavirin as treatment for chronic HCV hepatitis in a child cured of ALL.
authors.forename: Luca
authors.initials: L
authors.lastname: Lo Nigro
authors.forename: Milena
authors.initials: M
authors.lastname: La Spina
authors.forename: Elena
authors.initials: E
authors.lastname: Mirabile
authors.forename: Paola
authors.initials: P
authors.lastname: Pisana
authors.forename: Gino
authors.initials: G
authors.lastname: Schilirò
authors.forename: Paola
authors.initials: P
authors.lastname: Guardo
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a